AVH Share Price

Open 0.12 Change Price %
High 0.12 1 Day 0.00 0.00
Low 0.12 1 Week -0.02 -14.29
Close 0.12 1 Month 0.00 0.00
Volume 234888 1 Year 0.02 20.00
52 Week High 0.16
52 Week Low 0.09
AVH Important Levels
Resistance 2 0.12
Resistance 1 0.12
Pivot 0.12
Support 1 0.12
Support 2 0.12
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
AKK 0.01 0.00%
TON 0.09 -10.00%
TON 0.09 -10.00%
TON 0.09 -10.00%
FAR 0.07 0.00%
FAR 0.07 0.00%
FAR 0.07 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
PMQ 0.03 50.00%
OMH 0.18 28.57%
SRZ 0.05 25.00%
SRZ 0.05 25.00%
HGO 0.05 25.00%
HGO 0.05 25.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
RXL 0.01 -50.00%
RXL 0.01 -50.00%
RXL 0.01 -50.00%
GBA 0.02 -33.33%
DAU 0.02 -33.33%
More..

Avita Medical Ltd (ASX: AVH)

AVH Technical Analysis 1.5
As on 7th Dec 2016 AVH Share Price closed @ 0.12 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.11 & Sell for SHORT-TERM with Stoploss of 0.12 we also expect STOCK to react on Following IMPORTANT LEVELS.
AVH Target for December
1st Target up-side 0.16
2nd Target up-side 0.17
3rd Target up-side 0.18
1st Target down-side 0.12
2nd Target down-side 0.11
3rd Target down-side 0.1
AVH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.avitamedical.com
AVH Address
AVH
Beech House
Unit B1
Royston, SG8 6HB
United Kingdom
Phone: 44 1763 269770
Fax: 44 1763 269780
Interactive Technical Analysis Chart Avita Medical Ltd ( AVH ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Avita Medical Ltd
AVH Business Profile
Avita Medical Limited, a medical device company, develops and distributes regenerative medicine and respiratory products in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. The company develops and distributes tissue-engineered products for the treatment of wounds, scars, and other skin defects. Its lead product is ReCell, an autologous cell harvesting, processing, and delivery technology that enable collection of healthy skin cells for immediate treatment of existing scars created by burns, skin grafts, acne, acute wounds or surgery, and skin discolouration. The company also manufactures and sells a range of spacers, including Funhaler incentive asthma spacer for the paediatric market; and Breath-A-Tech spacer for the adolescent and adult markets. Avita Medical Limited is headquartered in Royston, the United Kingdom.